HEALTHLYNKED NEW Stock Price, News & Analysis
Company Description
HEALTHLYNKED NEW (OTC Link: HLYKD) is a publicly traded company.
HLYKD stock has declined 20.8% over the past year.
On a trailing twelve-month basis, HEALTHLYNKED NEW reported revenue of $3.0M with net income of -$6.1M and diluted earnings per share of $-0.02. The company operates at a net profit margin of -203.8%.
This page provides a comprehensive overview of HLYKD stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
HEALTHLYNKED NEW (HLYKD) stock. Over the past 12 months, the stock has lost 20.8%.
Latest News
SEC Filings
HEALTHLYNKED NEW has filed 2 recent SEC filings, including 1 Form 10-K, 1 Form NT 10-Q. The most recent filing was submitted on March 31, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all HLYKD SEC filings →
Financial Highlights
HEALTHLYNKED NEW generated $3.0M in revenue over the trailing twelve months, operating income reached -$4.7M (-155.5% operating margin), and net income was -$6.1M, reflecting a -203.8% net profit margin. Diluted earnings per share stood at $-0.02. The company generated -$3.5M in operating cash flow. With a current ratio of 0.35, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Short interest in HEALTHLYNKED NEW (HLYKD) currently stands at 2.4 thousand shares, up 674.7% from the previous reporting period. Over the past 12 months, short interest has increased by 674.7%.
Days to Cover History
Days to cover for HEALTHLYNKED NEW (HLYKD) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.